# US 2014/0154674 A1 · Methods and kits for isolation and analysis of a chromatin region

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0154674 A1
- Document ID: US20140154674A1
- Status: Published application
- Kind: A1
- Application number: 14/081,812
- Filed: 2013-11-15
- Published: 2014-06-05
- Earliest claimed: 2012-11-15
- Assignees: Board of Trustees of the University of Arkansas
- Applicants: Board of Trustees of University of Arkansas
- Inventors: Alan J. Tackett; Stephanie Byrum; Sean Taverna
- Web page: https://patentgrep.com/patent/US20140154674A1

## CPC

- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/6875: {Nucleoproteins}
- G01N 2440/00: Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- G01N 2570/00: Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention encompasses methods of identifying proteins and protein modifications of proteins specifically associated with a chromatin.

## Claims

### Claim 1

A method of identifying proteins including proteins comprising posttranslational modifications specifically associated with a target chromatin in a cell, the method comprising:
(a) providing:
i) a first cell sample comprising nucleic acid binding proteins and the target chromatin, wherein the target chromatin is tagged, and
ii) a second cell sample comprising nucleic acid binding proteins and the target chromatin, wherein the target chromatin is not tagged,
wherein the proteins in the first cell sample or the second cell sample are metabolically labeled,
(b) mixing the first cell sample and the second cell sample from (a) with an affinity handle to generate a cell mixture wherein the affinity handle binds protein such that the affinity handle specifically binds the tagged target chromatin and non-specifically binds nucleic acid binding proteins,
(c) isolating the affinity handle form the mixture in (b) wherein the affinity handle isolated consists of affinity handle bound to tagged target chromatin and affinity handle bound to nucleic acid binding proteins, wherein isolating the affinity handle isolates proteins associated with the tagged target chromatin,
(d) identifying isolated proteins from (c),
(e) determining whether each protein from (c) is metabolically labeled, unlabeled, or a mixture of labeled and unlabeled protein, wherein
i) if the first cell sample from (a) is not metabolically labeled and a protein associated with the target chromatin is not metabolically labeled, then the protein is specifically associated with the tagged chromatin in the cell, and
ii) if the first sample from (a) is metabolically labeled and a protein associated with the target chromatin is metabolically labeled, then the protein is specifically associated with the tagged chromatin in the cell.

### Claim 2 (depends on 1)

The method of claim 1, wherein the first cell sample is lysed before tagging the target chromatin.

### Claim 3 (depends on 1)

The method of claim 1, wherein the first cell sample is tagged before lysing the target chromatin.

### Claim 4 (depends on 3)

The method of claim 3, wherein the target chromatin is tagged by expressing protein A in a cell comprising the lexA nucleic acid binding site in the target chromatin.

### Claim 5 (depends on 1)

The method of claim 1, wherein the proteins in the first cell sample are metabolically labeled.

### Claim 6 (depends on 1)

The method of claim 1, wherein the proteins in the second cell sample are metabolically labeled.

### Claim 7 (depends on 1)

The method of claim 1, wherein the proteins in the first cell sample or the second cell sample are metabolically labeled with a heavy isotope.

### Claim 8 (depends on 1)

The method of claim 1, wherein the proteins in the first cell sample or the second cell sample are labeled by culturing cells in the presence of a labeled amino acid.

### Claim 9 (depends on 8)

The method of claim 8, wherein the labeled amino acid is [13C6, 15N4]-L-Arginine.

### Claim 10 (depends on 1)

The method of claim 1, wherein the proteins in the first cell sample and the second cell sample are crosslinked before lysis.

### Claim 11 (depends on 1)

The method of claim 1 wherein the first cell sample and the second cell sample are mixed at a ratio of 1:100 to 100:1.

### Claim 12 (depends on 1)

The method of claim 1 wherein the first cell sample and the second cell sample are mixed at a ratio of 1:1.

### Claim 13 (depends on 1)

The method of claim 1, wherein the chromatin in the lysate from step (b) is fragmented before isolating the tagged target nucleic acid sequence.

### Claim 14 (depends on 13)

The method of claim 13, wherein the chromatin in the lysate is fragmented to comprise nucleic acid sections comprising 500 to 1500 base pairs.

### Claim 15 (depends on 1)

The method of claim 1, wherein the tagged target nucleic acid sequence is isolated using affinity purification.

### Claim 16 (depends on 1)

The method of claim 1, wherein proteins associated with the target chromatin are identified using mass spectrometry.

### Claim 17 (depends on 1)

The method of claim 1, wherein mass spectrometry is used to determine if an identified protein associated with the target chromatin is labeled, unlabeled, or a combination of labeled and unlabeled protein.

### Claim 18 (depends on 1)

The method of claim 1, wherein if the first cell sample from (a) is not metabolically labeled and a protein associated with the target chromatin is metabolically labeled, or a combination of labeled and unlabeled protein, then the protein is not specifically associated with the tagged chromatin in the cell.

### Claim 19 (depends on 1)

The method of claim 1, wherein if the first cell sample from (a) is metabolically labeled and a protein associated with the target chromatin is not metabolically labeled, or a combination of labeled and unlabeled protein, then the protein is not specifically associated with the tagged chromatin in the cell.

### Claim 20 (depends on 1)

A kit for isolating and identifying proteins and post-translation modification of proteins specifically associated with a target chromatin, wherein the proteins and post-translation modification of proteins are identified using a method of claim 1.

### Claim 21

A method of identifying proteins including proteins comprising posttranslational modifications specifically associated with a target chromatin in a cell, the method comprising:
(a) providing:
i) a first cell sample comprising nucleic acid binding proteins and the target chromatin, wherein the target chromatin is tagged, and
ii) a second cell sample comprising nucleic acid binding proteins and the target chromatin, where in the target chromatin is not tagged,
(b) mixing each of the first cell sample and the second cell sample from (a) with an affinity handle wherein the affinity handle binds protein such that the affinity handle specifically binds the tagged target chromatin and non-specifically binds nucleic acid binding proteins,
(c) isolating the affinity handle from each mixture in (b) wherein affinity handle isolated from the first cell mixture consists of affinity handle bound to tagged target chromatin and affinity handle bound to nucleic acid binding proteins and affinity handle isolated from the second cell mixture consists of affinity handle bound to nucleic acid binding proteins, wherein isolating the affinity handle isolates proteins associated with the tagged target chromatin,
(d) identifying bound proteins from (c),
(e) determining the amount of each bound protein in each mixture from (c), wherein bound proteins that are enriched in the first cell mixture as compared to the second cell mixture are specifically associated with the tagged chromatin in the first cell sample,

### Claim 22 (depends on 21)

The method of claim 21, wherein the first cell sample is lysed before tagging the target chromatin.

### Claim 23 (depends on 21)

The method of claim 21, wherein the first cell sample is tagged before lysing the target chromatin.

### Claim 24 (depends on 23)

The method of claim 23, wherein a target chromatin is tagged by expressing in a cell protein A tagged TAL protein engineered to have binding specificity for a nucleic acid sequence component of the target chromatin.

### Claim 25 (depends on 21)

The method of claim 21, wherein the proteins in the first cell sample and the second cell sample are crosslinked before lysis.

### Claim 26 (depends on 21)

The method of claim 21, wherein the chromatin in the lysate from step (b) is fragmented before isolating the tagged target nucleic acid sequence.

### Claim 27 (depends on 26)

The method of claim 26, wherein the chromatin in the lysate is fragmented to comprise nucleic acid sections comprising 500 to 1500 base pairs.

### Claim 28 (depends on 21)

The method of claim 21, wherein the tagged target nucleic acid sequence is isolated using affinity purification.

### Claim 29 (depends on 21)

The method of claim 21, wherein proteins or protein fragments associated with the target chromatin are identified using mass spectrometry.

### Claim 30 (depends on 29)

The method of claim 29, wherein the proteins or protein fragments identified using mass spectrometry are quantified and identified as enriched in the sample containing the tagged target chromatin compared to the sample containing the untagged target chromatin using label-free proteomics.

### Claim 31 (depends on 30)

The method of claim 30, wherein the label-free proteomics technique is spectral counting.

### Claim 32 (depends on 30)

The method of claim 30, wherein proteins enriched in the sample containing the tagged target chromatin compared to the sample containing the untagged target chromatin are enriched by at least 2 fold.
